PL405505A1 - Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2 - Google Patents
Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2Info
- Publication number
- PL405505A1 PL405505A1 PL40550513A PL40550513A PL405505A1 PL 405505 A1 PL405505 A1 PL 405505A1 PL 40550513 A PL40550513 A PL 40550513A PL 40550513 A PL40550513 A PL 40550513A PL 405505 A1 PL405505 A1 PL 405505A1
- Authority
- PL
- Poland
- Prior art keywords
- acid derivative
- application
- biological activity
- diaminodicarboxylic acid
- diaminodicarboxylic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL40550513A PL405505A1 (pl) | 2013-09-30 | 2013-09-30 | Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2 |
PL417876A PL417876A1 (pl) | 2013-09-30 | 2014-09-29 | Zastosowania pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 i IL-2 |
PCT/IB2014/001939 WO2015044761A1 (fr) | 2013-09-30 | 2014-09-29 | Dérivé d'acide diaminodécanedioïque utile en tant qu'inhibiteur de l'activité de il -15 et de il -2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL40550513A PL405505A1 (pl) | 2013-09-30 | 2013-09-30 | Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL405505A1 true PL405505A1 (pl) | 2015-04-13 |
Family
ID=51947386
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL40550513A PL405505A1 (pl) | 2013-09-30 | 2013-09-30 | Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2 |
PL417876A PL417876A1 (pl) | 2013-09-30 | 2014-09-29 | Zastosowania pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 i IL-2 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL417876A PL417876A1 (pl) | 2013-09-30 | 2014-09-29 | Zastosowania pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 i IL-2 |
Country Status (2)
Country | Link |
---|---|
PL (2) | PL405505A1 (fr) |
WO (1) | WO2015044761A1 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL142536A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Carriers for therapeutic preparations for treatment of t-cell mediated diseases |
CU23472A1 (es) | 2004-09-17 | 2009-12-17 | Ct Ingenieria Genetica Biotech | Péptido antagonista de la interleucina-15 |
MX2008012053A (es) * | 2006-03-21 | 2008-12-17 | Joyant Pharmaceuticals Inc | Promotores de apoptosis de molecula pequeña. |
CU23716A1 (es) | 2008-09-30 | 2011-10-05 | Ct Ingenieria Genetica Biotech | Péptido antagonista de la actividad de la interleucina-15 |
JP5478082B2 (ja) * | 2009-01-20 | 2014-04-23 | 株式会社山田養蜂場本社 | インターロイキン−2産生抑制剤 |
-
2013
- 2013-09-30 PL PL40550513A patent/PL405505A1/pl unknown
-
2014
- 2014-09-29 WO PCT/IB2014/001939 patent/WO2015044761A1/fr active Application Filing
- 2014-09-29 PL PL417876A patent/PL417876A1/pl unknown
Also Published As
Publication number | Publication date |
---|---|
PL417876A1 (pl) | 2017-02-13 |
WO2015044761A1 (fr) | 2015-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501921A1 (en) | Novel compounds | |
CO2018011408A2 (es) | Compuestos de pirimidina como inhibidores de la quinasa jak | |
EA201591051A1 (ru) | Ингибиторы erk и варианты их применения | |
AR128259A2 (es) | Dihidropirimidinonas bicíclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrofílica | |
EA201691442A1 (ru) | N-азаспироциклоалканзамещенные n-гетероарильные соединения и композиции для ингибирования активности shp2 | |
CR20190156A (es) | Derivados de bipirazol como inhibidores jak | |
EA201391230A1 (ru) | Соединения и композиции в качестве ингибиторов trk | |
EA202091016A1 (ru) | Пиримидиновое соединение в качестве ингибитора jak киназы | |
PH12015501586A1 (en) | 2,3-dihydroimidazol[1,2-c]pyrimidin-5(1h)-one based lipoprotein-associated phospholipase a2 (lp-pla2) inhibitors | |
PH12019501362A1 (en) | Polymorphs | |
ECSP18026386A (es) | Sales de un inhibidor de pim quinasa | |
EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
UY35357A (es) | Dihidropirimidinonas bicíclicas sustituidas y su uso como inhibidores de la actividad de elastasa n eutrofílica | |
CO6612202A2 (es) | Inhibidores heterparílicos bicíclicos de pde4 | |
EA201790016A1 (ru) | АНАЛОГ ПИРИДИНО[1,2-a]ПИРИМИДОНА, ПРИМЕНЯЕМЫЙ В КАЧЕСТВЕ ИНГИБИТОРА PI3K | |
EA201990678A1 (ru) | Гетероарилкарбоксамидные соединения в качестве ингибиторов ripk2 | |
SA520412289B1 (ar) | مركبات مثبط الهدف الميكانيكي للراباميسين | |
PH12020550947A1 (en) | Polymorphs | |
EA201790282A1 (ru) | Замещенные бициклические дигидропиримидиноны и их применение в качестве ингибиторов активности нейтрофил-эластазы | |
CO6630197A2 (es) | Nuevos procesos | |
PL405505A1 (pl) | Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2 | |
PL405506A1 (pl) | Zastosowanie pochodnej kwasu 7-aminocefalosporanowego jako inhibitora aktywności biologicznej IL-15 i IL-2 | |
UA110882C2 (uk) | Фармацевтична композиція та спосіб її отримання | |
MX2015014702A (es) | Un compuesto para usarse en el tratamiento del transtorno de ansiedad comorbida y trastorno de depresion. | |
UY33584A (es) | Nuevos compuestos benzamida de inhibidores lrrk2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |